BenzingaDoubao · 实盘不做把握 8/10不做原因:无增量信息
北京时间·🕒 发布 23:20:38·⟳ 抓取 23:23:28 +2m50s·⚡ 决策 10-15 23:25:11 +1m43s·11.9 天前
摩根士丹利Q3业绩超预期后多家投行下调目标价，股价小跌1.1%
Benzinga此文是财报次日的分析师目标价汇总帖，非新公司事件；Q3超预期已在周三定价（周四仅-1.1%），五家目标价下调幅度温和($230/$205/$217/$205/$195)且全部高于现价$179.63，评级多维持Outperform，既不构成新利空做空催化，beat也已过期不宜追多，无正期望方向。
📄 原文Benzinga↗ 原文
Morgan Stanley Analysts Cut Their Forecasts After Q3 Results
Morgan Stanley (NYSE:MS) on Wednesday reported better-than-expected third-quarter 2026 results. The bank reported quart…
不做 Morgan Stanley（MS.US）
本条为财报次日的卖方目标价汇总，无增量事实：Q3双超预期已于周三定价，五家目标价仅小幅下调且全部高于现价$179.63、评级无一转空；做多beat已过期，做空又无强催化，多空均无正期望
展开详情(成交明细 / 研究档案 / 原文全文 / 决策记录链)
研究档案
结论摘要
摩根士丹利Q3盈利与营收双超预期、股票收入+41%，但真正催化周三已落地；本条只是五家投行小幅下调仍高于现价的目标价汇总，属滞后软信息，对超大市值银行无增量edge，多空均不做。
🔎 新鲜度:最早出现 2026-10-15 · 扩散 high · price-in 风险 high ↗
主要风险
- 若盘后出现管理层指引下修或交易业务景气逆转等新事实，需重新评估；本条汇总不含此类信息
反向证据
- 做空前查反向 · 来源 web · 日期 2026-10-15 · 影响 invalidates
反向证据：Q3 EPS与营收双超预期、股票收入+41%、机构证券收入$100亿，且五家目标价($195-$230)均高于现价、无一下调评级，缺乏强空催化
检索:Morgan Stanley Q3 2026 results beat, guidance raised, trading revenue outlook, buyback 原文 ↗ - 做多前查反向 · 来源 web · 日期 2026-10-15 · 影响 invalidates
反向证据：beat后股价周四仍跌1.1%，财报利好已在周三定价，本条无新惊喜，追多无新鲜edge
检索:Morgan Stanley stock reaction after Q3 earnings, shares fell Thursday 原文 ↗
先例如何影响了这次决策
对本次决策的影响:结论建立在本条无增量事实、无edge之上，历史先例不能改变这一判定，故不再检索同类目标价调整先例
工具执行结果 · 成功 1 · 降级 0 · 失败 0 · 取消 0
- search_processed_events 成功 stock_tools HTTP · 11 ms
{"result": "search_processed_events:agent query=`morgan stanley analyst price target cuts kbw evercore wells fargo td cowen rbc | morgan stanley q3 2026 earnings results eps 3.03 revenue 20.34 billion | ms stock q3 earnings equit`；结构化索引覆盖完整 72 小时；旧记录兼容扫描近 0.0/72 小时、0 条本臂决策(完整)，返回 0 条候选。未命中只表示这些 agen
原文全文
展开原文 · 1,606 字
Morgan Stanley (NYSE:MS) on Wednesday reported better-than-expected third-quarter 2026 results.
The bank reported quarterly earnings of $3.03 per share, beating the analyst consensus estimate of $2.92. Revenue rose to $20.34 billion, topping Wall Street’s estimate of $19.95 billion.
Institutional Securities generated $10 billion in net revenue, supported by strong equity trading and higher completed mergers and acquisitions.
Equity revenue climbed 41% to $5.8 billion, driven by increased client activity across regions, particularly in Asia.
Morgan Stanley shares fell 1.1% to trade at $179.63 on Thursday.
These analysts made changes to their price targets on Morgan Stanley following earnings announcement.
- Keefe, Bruyette & Woods analyst Christopher McGratty reiterated the stock with an Outperform rating and lowered the price target from $250 to $230.
- Evercore ISI Group analyst Glenn Schorr maintained the stock with an Outperform rating and cut the price target from $215 to $205.
- Wells Fargo analyst Mike Mayo maintained the stock with an Equal-Weight rating and lowered the price target from $223 to $217.
- TD Cowen analyst R. Scott Siefers maintained the stock with a Hold and lowered the price target from $210 to $205.
- RBC Capital analyst Gerard Cassidy maintained the stock with a Sector Perform and lowered the price target from $243 to $195.
Considering buying MS stock? Here’s what analysts think:
Photo via Shutterstock
© 2026 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
To add Benzinga News as your preferred source on Google, click here.
The bank reported quarterly earnings of $3.03 per share, beating the analyst consensus estimate of $2.92. Revenue rose to $20.34 billion, topping Wall Street’s estimate of $19.95 billion.
Institutional Securities generated $10 billion in net revenue, supported by strong equity trading and higher completed mergers and acquisitions.
Equity revenue climbed 41% to $5.8 billion, driven by increased client activity across regions, particularly in Asia.
Morgan Stanley shares fell 1.1% to trade at $179.63 on Thursday.
These analysts made changes to their price targets on Morgan Stanley following earnings announcement.
- Keefe, Bruyette & Woods analyst Christopher McGratty reiterated the stock with an Outperform rating and lowered the price target from $250 to $230.
- Evercore ISI Group analyst Glenn Schorr maintained the stock with an Outperform rating and cut the price target from $215 to $205.
- Wells Fargo analyst Mike Mayo maintained the stock with an Equal-Weight rating and lowered the price target from $223 to $217.
- TD Cowen analyst R. Scott Siefers maintained the stock with a Hold and lowered the price target from $210 to $205.
- RBC Capital analyst Gerard Cassidy maintained the stock with a Sector Perform and lowered the price target from $243 to $195.
Considering buying MS stock? Here’s what analysts think:
Photo via Shutterstock
© 2026 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
To add Benzinga News as your preferred source on Google, click here.
决策记录链 · 只追加
每次领取产生一条记录,重新决策追加一条并以 supersedes 指向被替代的记录(ADR 0014)。
9f3fcb973a· 2026-10-15 23:25 · doubao / doubao-seed-evolving-latest-version · 策略包2226518bfdee当前